Dyrness Albert D. is a director of Sonnet BioTherapeutics Holdings Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sonnet BioTherapeutics Holdings, Inc.
31 May 23
4
Sonnet BioTherapeutics Holdings, Inc.
22 Dec 22
4
Sonnet BioTherapeutics Holdings, Inc.
8 Apr 22
4
Sonnet BioTherapeutics Holdings, Inc.
2 Jul 20
4
Sonnet BioTherapeutics Holdings, Inc.
12 Jun 20
4
Sonnet BioTherapeutics Holdings, Inc.
3 Apr 20
3
Sonnet BioTherapeutics Holdings, Inc.
3 Apr 20
4
Oncobiologics, Inc.
30 Oct 17
4
Oncobiologics, Inc.
27 Dec 16
3
Oncobiologics, Inc.
12 May 16
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 May 23 | SONN Sonnet BioTherapeutics | Common Stock | Buy | Acquire P | No | No | 0.468 | 23,255 | 10.88 k | 28,962 |
14 Dec 22 | SONN Sonnet BioTherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,770 | 0.00 | 30,893 |